The "Malaria and Typhoid" Scam in Nigeria

The "Malaria and Typhoid" Scam in Nigeria: 

For Igbenews-Adeboye Prince Adetu 

A Call for Smarter Healthcare Choices

The Widal Test: An Unreliable Diagnostic Tool

The widespread use of the Widal agglutination test for typhoid fever diagnosis in Nigeria has been identified by medical experts as fundamentally flawed. Research published in the Malaria Journal has described the Widal test as "notoriously inaccurate" and "considered outdated". Serological testing for typhoid fever remains unsatisfactory, and a positive result in an endemic population does not necessarily indicate active infection.

A study conducted at the University of Benin Teaching Hospital evaluating the validity of the Widal test compared to blood culture (the gold standard for typhoid diagnosis) revealed alarming findings: the Widal test had a sensitivity of only 35% and a specificity of just 51%. Perhaps most concerning, the positive predictive value was only 17%—meaning that fewer than 1 in 5 people who test positive actually have typhoid fever. The study concluded that "a single Widal agglutination test is not a valid diagnostic option for typhoid fever".

The Malaria Testing Paradox in an Endemic Setting

In Nigeria, where malaria is hyperendemic, routine testing of healthy individuals presents a different but equally significant problem. According to international convention, the diagnosis of malaria in a clinical setting must be based on the "direct detection of the parasite"—through microscopy, rapid antigen testing, or PCR. Serology "cannot differentiate past from active infection and is, therefore, irrelevant as diagnostic tool in the clinical setting".

This is critical because in a country where nearly everyone is repeatedly bitten by infected mosquitoes, many people will have detectable malaria antibodies or parasites without having active disease requiring treatment. The National Guidelines for Diagnosis and Treatment of Malaria in Nigeria recommend parasitological confirmation (microscopy or RDT) for children above 5 years and adults, but crucially, the policy allows syndromic diagnosis—based on history and clinical examination—for children under five. The key takeaway: testing without symptoms is clinically meaningless.

The Cross-Reactivity Problem

Research has established a significant statistical association between the presence of malaria parasites and a positive Widal test result. A study found that "the presence of malaria parasites in a patient could produce a false positive Widal test result" due to cross-reacting antigens between the malaria parasite and Salmonella typhi. This explains the apparently "high rate" of typhoid fever diagnosed in Nigerian healthcare facilities—it is often a false positive driven by underlying malaria parasitemia.

Health Anxiety: The Fuel Behind the Scam

The concept of hypochondriasis—health anxiety—is gaining recognition in Nigeria. A study conducted during the COVID-19 pandemic in Calabar found that 91% of respondents presented with nosophobia and hypochondriasis, with slightly higher prevalence in women. Additionally, research on cyberchondria among Nigerian undergraduates found that 50.4% exhibited symptoms of this condition, driven by factors including recurrent health concerns (70.4%), the need to verify diagnoses (70.1%), high healthcare costs (79.2%), and social media influence (78.1%).

This persistent health anxiety creates a perfect market for unscrupulous healthcare providers who exploit patients' fears, running unnecessary tests and prescribing unneeded medications.

The Hidden Danger: Frequent "Malaria/Typhoid" Treatment May Signal Something Worse

Medical experts are now warning that Nigerians who are diagnosed and treated for malaria or typhoid more than 10 times in a year may unknowingly be suffering from a more serious condition—lupus, a chronic autoimmune disease that mimics other illnesses and is notoriously difficult to detect. A Consultant Rheumatologist at LASUTH explained that lupus often presents with symptoms like malaria or typhoid—fever, weakness, and body pains—leading to years of misdiagnosis. The message: if you are "treating malaria and typhoid" monthly and it never resolves, you likely never had malaria or typhoid in the first place.

A Better Use of Your Healthcare Resources

The Nigerian healthcare community increasingly advocates for preventive health screenings rather than chasing phantom infections. Physicians recommend that everyone from age 30 and above, especially those with a family history of hypertension, check their blood pressure every six months. Blood sugar testing is equally important, with experts stressing that "many Nigerians living with hypertension, diabetes, and other chronic health issues are unaware of their health conditions".

Non-communicable diseases now account for approximately 29–30% of all deaths in Nigeria, according to the Federal Ministry of Health and WHO. Hypertension, for example, "may exist for a decade before a person becomes aware"—often after a stroke, heart attack, or kidney failure. The recommended annual health screening includes blood pressure checks, fasting blood glucose, lipid profile, and kidney and liver function tests.

Conclusion

· If you feel well, there is no need for malaria or typhoid tests.
· If you have symptoms (fever with vomiting, severe headache, bloody diarrhea, inability to eat/drink, recent travel, or new bitter taste), testing is appropriate.
· If you're repeatedly diagnosed with malaria/typhoid without resolution, consider seeking a specialist evaluation for conditions like lupus.
· Redirect your health resources to regular blood pressure and blood sugar checks—these are the silent killers you won't feel coming.

Your health is your wealth. Don't waste it chasing diseases you don't have while ignoring the ones that could truly harm you.

Comments

Popular posts from this blog

Babanbola and scavengers banned in igbe town

STOP SELLING YOUR CONDEMNED PHONES – YOU ARE HELPING BOKO HARAM FIGHT NIGERIA

Ilupeju Secondary School's Pioneer Set (84/85) Evolves into Elders Forum at 200th Meeting